136 related articles for article (PubMed ID: 6203337)
41. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
42. [Enzyme diagnosis in primary liver carcinoma].
Schmidt E; Schmidt FW
Dtsch Med Wochenschr; 1968 Jun; 93(23):1153-5. PubMed ID: 5648362
[No Abstract] [Full Text] [Related]
43. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
44. [Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein].
Matsuyama H; Morishita Y; Nakane K; Fukatsu T; Nakashima N
Rinsho Byori; 1994 Oct; 42(10):1021-8. PubMed ID: 7527871
[TBL] [Abstract][Full Text] [Related]
45. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
46. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
[TBL] [Abstract][Full Text] [Related]
47. Changes in liver function after hepatic dearterialization in man.
Nagasue N; Murakami H; Ayabe K; Ichimaru K; Araki S
Jpn J Surg; 1973 Mar; 3(1):40-51. PubMed ID: 4140255
[No Abstract] [Full Text] [Related]
48. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
Lee E; Edward S; Singal AG; Lavieri MS; Volk M
Clin Gastroenterol Hepatol; 2013 Apr; 11(4):437-40. PubMed ID: 23247324
[TBL] [Abstract][Full Text] [Related]
49. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
50. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
[TBL] [Abstract][Full Text] [Related]
51. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
53. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
54. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
[TBL] [Abstract][Full Text] [Related]
55. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
56. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
[TBL] [Abstract][Full Text] [Related]
57. Liver function during amantadine hydrochloride medication in compensated liver disease.
Schnack H; Wewalka F; Guttmann G
Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):185-7. PubMed ID: 5800713
[No Abstract] [Full Text] [Related]
58. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong.
Lai CL; Lam KC; Wong KP; Wu PC; Todd D
Cancer; 1981 Jun; 47(11):2746-55. PubMed ID: 6266641
[TBL] [Abstract][Full Text] [Related]
59. Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.
Takagi H; Kakizaki S; Sohara N; Sato K; Tsukioka G; Tago Y; Konaka K; Kabeya K; Kaneko M; Takayama H; Hashimoto Y; Yamada T; Takahashi H; Shimojo H; Nagamine T; Mori M
Int J Vitam Nutr Res; 2003 Nov; 73(6):411-5. PubMed ID: 14743544
[TBL] [Abstract][Full Text] [Related]
60. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Collazos J
Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]